Cargando…
Polyglutamine Disease Modeling: Epitope Based Screen for Homologous Recombination using CRISPR/Cas9 System
We have previously reported the genetic correction of Huntington’s disease (HD) patient-derived induced pluripotent stem cells using traditional homologous recombination (HR) approaches. To extend this work, we have adopted a CRISPR-based genome editing approach to improve the efficiency of recombin...
Autores principales: | An, Mahru C., O'Brien, Robert N., Zhang, Ningzhe, Patra, Biranchi N., De La Cruz, Michael, Ray, Animesh, Ellerby, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994193/ https://www.ncbi.nlm.nih.gov/pubmed/24761311 http://dx.doi.org/10.1371/currents.hd.0242d2e7ad72225efa72f6964589369a |
Ejemplares similares
-
Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells
por: Zhang, Ningzhe, et al.
Publicado: (2010) -
Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation
por: Teuling, Eva, et al.
Publicado: (2011) -
Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
por: Dorsey, Ray, et al.
Publicado: (2011) -
Stability of white matter changes related to Huntington’s disease in the presence of
imaging noise: a DTI study
por: Müller, Hans-Peter, et al.
Publicado: (2011) -
Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions"
por: Vaccarino, Anthony L, et al.
Publicado: (2011)